XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities:    
Net income (loss) $ 5,586 $ (17,801)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Non-cash lease expense 199 209
Depreciation and amortization 367 245
Stock-based compensation 552 409
Provision for uncollectible accounts   999
Unrealized exchange (gain) or loss 314 (88)
Provision for inventory 209  
Change in fair value of warrant liabilities (3,131) 1,475
Change in fair value of derivative liabilities 62 29
Change in fair value of Revenue Interest Financing and PIPE Conversion Option (1,490)  
Change in fair value of earn-out liabilities (14,190)  
Non-cash interest expense 315 317
Changes in operating assets and liabilities:    
Accounts receivable 1,673 (427)
Inventory 330 (449)
Prepaid expenses, other current and long-term assets 244 36
Lease liabilities (238) (175)
Accounts payable 1,551 5,354
Accrued expenses and other current liabilities (989) (451)
Net cash used in operating activities (8,636) (10,318)
Investing Activities:    
Purchases of property and equipment (104) (277)
Net cash used in investing activities (104) (277)
Financing Activities:    
Proceeds from issuance of convertible notes - net   13,600
Proceeds from option and warrant exercises 9 32
Proceeds from equity line financing 378  
Payment of deferred financing costs   (766)
Net cash provided by financing activities 387 12,866
Net increase (decrease) in cash and cash equivalents and restricted cash (8,353) 2,271
Cash and cash equivalents and restricted cash at beginning of period 38,421 8,023
Cash and cash equivalents and restricted cash at end of period 30,068 10,294
Supplemental disclosure of cash flow information    
Cash paid for interest 1,831 1,920
Supplemental cash flow information on non-cash investing and financing activities    
Purchase of property and equipment included in accounts payable 73 174
Deferred financing costs in accounts payable and accrued expenses   $ 2,634
Change in fair value of Revenue Interest Financing through OCI $ (2,200)